INTERCEPT PHARMACEUTICALS IN

CUSIP: 45845PAA6 Class: NOTE 3.250% 7/0

PRELUDE CAPITAL MANAGEMENT, LLC's Holding History (CIK: 0001387508)

Note: Option positions (PUT/CALL) are excluded.

Q4 2021
Shares 200,000 Value ($000) $189 Avg Close — Range —
Q3 2021
Shares 200,000 Value ($000) $180 Avg Close — Range —
Q2 2021
Shares 200,000 Value ($000) $180 Avg Close — Range —
Q1 2021
Shares 200,000 Value ($000) $164 Avg Close — Range —